The head-to-head data is equally decisive
The 2024 multi-society guidance The 2024 multi-society guidance substantially changed the clinical approach
References & Further Reading The information in this blog post was gathered from reputable medical, academic, and nutritional sources, including: Cleveland Clinic Overview of GLP-1 receptor agonists, their function, and medical applications Harvard Health Publishing Review of side effects, nutritional concerns, and long-term risks associated with GLP-1 medication use UC Davis Health Insights into how GLP-1 hormones affect whole-body health beyond weight loss UChicago Medicine Current research on GLP-1 medications and metabolic benefits Standard Process Official Resources Product details, whole-food philosophy, farming practices, and supplement benefits Whole Pet Clinic Standard Process Overview (human supplement explanation) Summary of whole-food nutrient advantages
Semaglutide in patients with heart failure with preserved ejection fraction and obesity
C.VarelaJ
Eli Lilly and Company press release, 2026